Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anxiety, Dry skin, Rash, SARS-CoV-2 test
Clinical narrative: skin still dried out; 48 hours later developed a rash ,rash from head to toes, Itchy rash, scaly rash, nasty rash/rash has improved but she still gets random splotches all over her body.; the worst anxiety/anxiety on a daily basis; This spontaneous case was reported by a consumer and describes the occurrence of DRY SKIN (skin still dried out), ANXIETY (the worst anxiety/anxiety on a daily basis) and RASH (48 hours later developed a rash ,rash from head to toes, Itchy rash, scaly rash, nasty rash/rash has improved but she still gets random splotches all over her body.) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033H21A, 043B21A and 018B21A) for COVID-19 vaccination.     No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  The patient's past medical history included COVID-19 (Patient stated she was diagnosed with COVID-19 sometime after first and 2nd Moderna vaccination.) in 2021. Concurrent medical conditions included Seasonal allergy, Asthma (Patient reported that it started many years ago. Recent change in status: Worsening), Cardiac disorder NOS (Heart patient. Start date was prior to Moderna vaccines. No change in status recently.) and Diabetic (Start date was prior to Moderna vaccines. No change in status recently.).   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 07-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 07-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ANXIETY (the worst anxiety/anxiety on a daily basis). On 09-Jan-2022, the patient experienced RASH (48 hours later developed a rash ,rash from head to toes, Itchy rash, scaly rash, nasty rash/rash has improved but she still gets random splotches all over her body.). On an unknown date, the patient experienced DRY SKIN (skin still dried out). At the time of the report, DRY SKIN (skin still dried out) and ANXIETY (the worst anxiety/anxiety on a daily basis) had not resolved and RASH (48 hours later developed a rash ,rash from head to toes, Itchy rash, scaly rash, nasty rash/rash has improved but she still gets random splotches all over her body.) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive: Sometime after first Moderna vaccine and positive (Positive) Positive: Sometime after second Moderna vaccine.         No concomitant medications were reported by the reporter. Patient mentioned that went to see a dermatologist about the rash and reported has been given "many shots of steroids" and steroid cream. Patient also reported she was using lotion. Patient stated she has seen the dermatologist a total of two times. Patient reported the rash was "under control to a tolerable level". She mentioned she never had to deal with anxiety on a daily basis in the past prior to receiving Moderna booster dose. Patient stated she will not be getting the second Moderna booster dose due to the rash she experienced from the first booster dose. The treatment include Steroid injections.   This case was linked to MOD-2022-548561, MOD-2022-548556 (Patient Link).   Reporter did not allow further contact